Revolutionary type topical anesthetic ELA-Max works fast and lasts long
A study conducted by Drs. David Altman and Stuart Gildenberg of St. John’s Macomb Hospital Center in Warren, Michigan, recently published in Dermatologic Surgery, showed that the topical anesthetic EMLA required 90 minutes of occluded contact with the skin to provide the same amount of pain relief as the new, revolutionary topical ELA-Max, after only 15 minutes of unoccluded contact. A number of other clinical studies are underway to demonstrate the versatility of ELA-Max in relieving pain during procedures for which a topical anesthetic is indicated.
Topical anesthetic creams and gels are used widely for the prevention of pain associated with insect bites, sunburn, as well as many commonly performed medical procedures. They are used prior to esthetic laser surgery such as skin resurfacing for wrinkles and scars, leg veins and facial blood vessels, birthmarks, age spots, as well for reducing the pain associated with minor dermatology procedures such as collagen injections, wart removal and skin tags.
The onset, depth, and duration of dermal anesthesia is dependent upon how long the product is kept in contact with the skin. ELA-Max, containing 4% lidocaine, is different from other topical anesthetic creams because it features a patented liposomal delivery system that facilitates enhanced penetration, minimal irritation, greater concentration and residence time in the dermis and epidermis without the requirement for an occlusive bandage. It is also less expensive than other topical anesthetic creams.
ELA-Max was developed jointly by Ferndale Laboratories of Michigan, U.S.A., and Biozone. Biozone provides the liposome-encapsulated lidocaine and Ferndale blends the cream vehicle and liposomes together to form the final product. Though approved by the U.S. Food and Drug Administration, and available without prescription, ELA-Max is currently marketed to plastic surgeons, electrologists and dermatologists. It comes in 5- and 30-gram tubes, and is available through authorized distributors, major drug wholesalers and most pharmacies. Wholesale pricing is available to the electrologist through PDRX and Henry Schein. Full-color application instructions are available.
More information about ELA-Max 4% Lidocaine Topical Anesthetic Cream may be obtained by contacting Ferndale Laboratories, Inc. at 1-877-ELAMax4 (352 6294) or fax at 248-548-8427.
home
subscribe
advertise
about us
